Randomized phase II Trial comparing Lenalidomide with lowdose dexamethasone versus Lenalidomide in Second Line Multiple Myeloma (MM)
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 24 Mar 2016 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
- 25 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 28 Jul 2012 Additional location (Denmark) added as reported by European Clinical Trials Database.